Evidence map›Paper›PMID 29291708›Full record

Trial reportBMC public health2018

Determinants of weight outcomes in type 2 diabetes prevention intervention in primary health care setting (the DE-PLAN project).

Aleksandra Gilis-Januszewska, Beata Piwońska-Solska, Jaana Lindström, Ewa Wójtowicz, Jaakko Tuomilehto, Peter E H Schwarz, Katarzyna Kissimova-Skarbek, Zbigniew Szybiński, Adam Windak, Alicja Hubalewska-Dydejczyk

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

  • Commented on by
    2018
5 · Who and what money

Authors and funding

10 authors at 4 institutions in 6 countries.

Aleksandra Gilis-JanuszewskaDepartment of Endocrinology, Jagiellonian University, Medical College, ul. Kopernika 17, 31-501, Krakow, Poland. myjanusz@cyfronet.pl.ORCID 0000-0002-9982-6499
Beata Piwońska-SolskaDepartment of Endocrinology, Jagiellonian University, Medical College, ul. Kopernika 17, 31-501, Krakow, Poland.
Jaana LindströmChronic Disease Prevention Unit, National Institute for Health and Welfare(THL), Helsinki, Finland.
Ewa WójtowiczDepartment of Endocrinology, Jagiellonian University, Medical College, ul. Kopernika 17, 31-501, Krakow, Poland.
Jaakko TuomilehtoCentre for Vascular Prevention, Danube-University Krems, Krems, Austria.
Peter E H SchwarzDepartment for Prevention & Care of Diabetes, Medical Clinic Unit III, University Clinic Carl Gustav Carus at Technical University Dresden, Dresden, Germany.
Katarzyna Kissimova-SkarbekDepartment of Health Economics and Social Security, Institute of Public Health, Jagiellonian University, Medical College, Krakow, Poland.
Zbigniew SzybińskiDepartment of Endocrinology, Jagiellonian University, Medical College, ul. Kopernika 17, 31-501, Krakow, Poland.
Adam WindakDepartment of Family Medicine, Chair of Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland.
Alicja Hubalewska-DydejczykDepartment of Endocrinology, Jagiellonian University, Medical College, ul. Kopernika 17, 31-501, Krakow, Poland.
Jagiellonian University · PLFinnish Institute for Health and Welfare · FIUniversität für Weiterbildung Krems · ATUniversity Hospital Carl Gustav Carus · DE

Funding

Fourth Framework Programme grant agreement no. 2004310Ministerstwo Nauki i Szkolnictwa Wyższego grant agreement no 40/PUBLIC HEALTH 2004/2006/7
6 · The paper itself

Abstract

backgroundReal life implementation studies performed in different settings have proved that lifestyle interventions in the prevention of type 2 diabetes (DM2) can be effective, although the weight reduction results are typically modest compared to randomized control trials. Our objective was to identify the factors that predict successful weight loss in a less intensive, lower budget, real life setting lifestyle diabetes prevention intervention.

methodsStudy participants (n = 175) with increased DM2 risk (Finnish Diabetes Risk Score (FINDRISC) > 14) but no diabetes at baseline received ten group lifestyle counselling sessions, physical activity and motivation sessions during a ten-month intervention. Stepwise regression analysis was used to determine demographic, clinical, and lifestyle predictors of successful weight reduction defined as a reduction of ≥5% of the initial body weight.

resultsAt 12 months following the initiation of the intervention, 23.4% of study participants lost ≥5% weight (mean loss of 7.9 kg, SD = 5.8). Increased physical activity (44% vs 25%, p = 0.03), decreased total fat consumption (88% vs 65%, p = 0.006) and adherence to four-five lifestyle goals (71% vs 46%, p = 0.007) were more often reported among those who managed to lose ≥5% weight versus those who did not. In a multivariate analysis, meeting the ≥5% weight loss goal was most effective in individuals with a higher baseline BMI (OR 1.1, 95%CI 1.0-1.2), baseline and medium versus higher education (OR 5.4, 95% CI 1.2-24.7) and a history of increased glucose (OR 2.6, 95%CI 1.1-1.3). A reduction of total fat in the diet was an independent lifestyle predictor, increasing the probability of successful weight loss by 3.8 times (OR 3.8, 95% CI 1.2-11.4).

conclusionBaseline higher BMI, lower education and a history of increased glucose predicted the successful weight loss among individuals with a high risk for the DM2 following lifestyle intervention in a real life primary health care setting. People who manage to lose weight more often adhere to lifestyle changes, while the reduction of total fat in diet independently predicts successful weight loss. Further studies exploring the predictors of success in implementation studies in DM2 prevention should help health care providers redesign interventions to improve their effectiveness and outcomes.

trial registrationISRCTN, ID ISRCTN96692060 , registered 03.08.2016 retrospectively.

Indexed as

Life StylePrimary Health CareWeight LossAdultAgedDiabetes Mellitus, Type 2FemaleHumansMaleMiddle AgedTreatment OutcomeDeterminants of weight lossDietLifestyle interventionPhysical activityPreventionReal life settingType 2 diabetesWeight loss

Identifiers

PMID29291708
PMCPMC5749019
OpenAlexW2781664466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.